Literature DB >> 7003716

Chemotherapy of advanced Hodgkin's disease.

C A Coltman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003716

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  9 in total

Review 1.  Minimising the side effects of cancer chemotherapy in senior patients.

Authors:  T Kinzel; V Feleppa
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 2.  Current management of Hodgkin's disease.

Authors:  B C Behrens; R C Young; V T DeVita
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

3.  Prognosis of Hodgkin's disease in India.

Authors:  B D Gupta
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

4.  Therapy for advanced Hodgkin's disease.

Authors:  V P Choudhry
Journal:  Indian J Pediatr       Date:  1982 Nov-Dec       Impact factor: 1.967

5.  Management of childhood lymphomas - Hodgkin's disease and non-Hodgkin's lymphomas.

Authors:  C C Patel
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

6.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

7.  Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.

Authors:  N J DiBella; R Berris; D Garfield; K Fink; J Speer; A Sakamoto
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

8.  [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors:  W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal:  Klin Wochenschr       Date:  1981-03-16

9.  Chemotherapy of lung cancer.

Authors:  R J Papac
Journal:  Yale J Biol Med       Date:  1981 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.